Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

LFVN Lifevantage Corp

Price (delayed)

$13.05

Market cap

$164.28M

P/E Ratio

17.4

Dividend/share

$0.17

EPS

$0.75

Enterprise value

$154.16M

LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced ...

Highlights
LFVN's EPS has soared by 168% YoY and by 25% QoQ
The net income has soared by 154% YoY and by 25% from the previous quarter
LFVN's quick ratio is down by 9% year-on-year and by 8% since the previous quarter

Key stats

What are the main financial stats of LFVN
Market
Shares outstanding
12.59M
Market cap
$164.28M
Enterprise value
$154.16M
Valuations
Price to earnings (P/E)
17.4
Price to book (P/B)
4.82
Price to sales (P/S)
0.72
EV/EBIT
12.28
EV/EBITDA
8.96
EV/Sales
0.69
Earnings
Revenue
$222.35M
Gross profit
$178.53M
Operating income
$12.96M
Net income
$9.15M
EBIT
$12.56M
EBITDA
$17.21M
Free cash flow
$11.98M
Per share
EPS
$0.75
EPS diluted
$0.69
Free cash flow per share
$0.97
Book value per share
$2.71
Revenue per share
$18
TBVPS
$6.24
Balance sheet
Total assets
$77.24M
Total liabilities
$43.23M
Debt
$12.36M
Equity
$34.01M
Working capital
$21.53M
Liquidity
Debt to equity
0.36
Current ratio
1.66
Quick ratio
0.79
Net debt/EBITDA
-0.59
Margins
EBITDA margin
7.7%
Gross margin
80.3%
Net margin
4.1%
Operating margin
5.8%
Efficiency
Return on assets
13.7%
Return on equity
31.1%
Return on invested capital
36.3%
Return on capital employed
28.1%
Return on sales
5.6%
Dividend
Dividend yield
1.26%
DPS
$0.17
Payout ratio
22%

LFVN stock price

How has the Lifevantage stock price performed over time
Intraday
2.76%
1 week
3.08%
1 month
5.5%
1 year
71.71%
YTD
-25.56%
QTD
-10.49%

Financial performance

How have Lifevantage's revenue and profit performed over time
Revenue
$222.35M
Gross profit
$178.53M
Operating income
$12.96M
Net income
$9.15M
Gross margin
80.3%
Net margin
4.1%
The company's operating margin has surged by 190% YoY and by 14% QoQ
The net income has soared by 154% YoY and by 25% from the previous quarter
The net margin has soared by 128% YoY and by 17% from the previous quarter
LFVN's operating income is up by 20% since the previous quarter

Price vs fundamentals

How does LFVN's price correlate with its fundamentals

Growth

What is Lifevantage's growth rate over time

Valuation

What is Lifevantage stock price valuation
P/E
17.4
P/B
4.82
P/S
0.72
EV/EBIT
12.28
EV/EBITDA
8.96
EV/Sales
0.69
LFVN's EPS has soared by 168% YoY and by 25% QoQ
The price to earnings (P/E) is 37% less than the last 4 quarters average of 27.7 and 19% less than the 5-year quarterly average of 21.6
The price to book (P/B) is 46% higher than the 5-year quarterly average of 3.3 but 9% lower than the last 4 quarters average of 5.3
The company's equity rose by 27% YoY and by 14% QoQ
The P/S is 44% more than the 5-year quarterly average of 0.5 and 2.9% more than the last 4 quarters average of 0.7
The revenue has increased by 8% year-on-year and by 4.8% since the previous quarter

Efficiency

How efficient is Lifevantage business performance
LFVN's ROS has soared by 180% YoY and by 14% QoQ
LFVN's return on equity has surged by 155% year-on-year and by 17% since the previous quarter
The company's return on assets has surged by 145% YoY and by 17% QoQ
The return on invested capital is up by 22% since the previous quarter

Dividends

What is LFVN's dividend history
DPS
$0.17
Dividend yield
1.26%
Payout ratio
22%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lifevantage financials performed over time
Lifevantage's total assets is 79% more than its total liabilities
Lifevantage's total assets has increased by 26% YoY and by 13% from the previous quarter
The company's total liabilities rose by 25% YoY and by 12% QoQ
The debt is 64% less than the equity
The company's debt to equity fell by 29% YoY and by 16% QoQ
The company's equity rose by 27% YoY and by 14% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.